Recent News

rss

Important Information

from the State Medical Board of Ohio

Licensees Invited: A Closer Look at Addiction Treatment - Ideas in Practice

Licensees Invited: A Closer Look at Addiction Treatment - Ideas in Practice

Our licensees are invited to join us for a statewide, collaborative meeting about the opioid epidemic in Ohio and the need for a continuum of care for addiction treatment. At this event, we ask you to share your thoughts with other health care leaders from across Ohio as we work to incorporate opioid treatment and evidence-based practices in a range of health care settings.

 

September 25, 2017, 8:30 a.m. to 3:30 p.m.

The Ohio State University’s 4-H conference center, Columbus

-or-

One of 18 additional live-stream locations across Ohio

The opioid epidemic and consequences of substance abuse are devastating the country. We must do more to end this epidemic. The continuum of care models exist to deal with substance abuse, opioid abuse and prescription pill abuse. This conference will highlight best practices, American Society of Addiction Medicine’s (ASAM) Standards of Care, community partnerships and replicable models currently in practice.

 

AMA Credit Designation Statement:

The American Society of Addiction Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

ACCME Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of The American Society of Addiction Medicine and The Office of the Attorney General of Ohio, Substance Use and Populations Health Initiatives. The American Society of Addiction Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

Please see the image above for information on the day’s agenda. To register for Columbus or one of the other statewide locations, please visit www.OhioAttorneyGeneral.gov/OpiateAbuse.

 

New Limits on Prescription Opioids for Acute Pain

New Limits on Prescription Opioids for Acute Pain

Effective August 31, 2017, the State of Ohio will have new rules for prescribing opioid analgesics for the treatment of acute pain.  Please be advised, these rules DO NOT apply to the use of opioids for the treatment of chronic pain. Click here to watch the educational video/overview.

In general, the rules limit the prescribing of opioid analgesics for acute pain, as follows:

  1. No more than seven days of opioids can be prescribed in the initial prescription for adults.

  2. No more than five days of opioids can be prescribed in the initial prescription for minors, and only after the written consent of the parent or guardian is obtained.

  3. Health care providers may prescribe opioids in excess of the day supply limits only if they provide a specific reason in the patient’s medical record.

  4. Except as provided for in the rules, the total morphine equivalent dose (MED) of a prescription for acute pain cannot exceed an average of 30 MED per day.

  5. The new limits do not apply to opioids prescribed for cancer, palliative care, end-of-life/hospice care or medication-assisted treatment for addiction.

NOTE: These rules do not apply to veterinarians.

 

Starting December 29, 2017, rule 4729-5-30 will require prescribers to include the first four characters (ex. M16.5) of the diagnosis code (ICD-10) or the full procedure code (Current Dental Terminology - CDT) on opioid prescriptions, which will be entered by the pharmacy into Ohio’s prescription monitoring program, OARRS.  This requirement will take effect for all other controlled substance prescriptions on June 1, 2018.  NOTE: This requirement does not apply to veterinarians.

Starting December 29, 2017, rule 4729-5-30 will also require prescribers to indicate the days’ supply on all controlled substance and gabapentin prescriptions. NOTE: This requirement does not apply to veterinarians.

 

To assist prescriber’s in calculating a patient’s morphine equivalent dose, the State of Ohio Board of Pharmacy has developed a conversion chart that can be accessed here: www.pharmacy.ohio.gov/MEDtable.

For additional information, please review your licensing board’s respective rules and the Board of Pharmacy’s manner of issuance rule:

 

Medical Board - Rules for Physicians and Physician Assistants

4731-11-01 - Definitions (related to controlled substances)
4731-11-02 - General provisions (related to controlled substances)
4731-11-13 - Prescribing of opioid analgesics for acute pain

Dental Board

4715-6-02 - Prescribing opioid analgesics for acute pain

Nursing Board

4723-9-10 - Formulary; standards of prescribing for advanced practice registered nurses designated as clinical nurse specialists, certified nurse-midwives, or certified nurse practitioners.

Pharmacy Board

4729-5-30 - Manner of issuance of a prescription.  (NOTE: This rule will not go into effect until December 29, 2017.  The Board has adopted a resolution regarding the diagnosis/procedure code provisions of this rule: www.pharmacy.ohio.gov/AcuteResolution)

 

Prescribing Opioids for the Treatment of Chronic Pain

As a reminder, Ohio developed guidelines for the treatment of chronic pain using opioids.  These guidelines can be accessed here.

 

For More Information

If you are a prescriber, please contact your respective regulatory board using the information below.

Upcoming Holiday Closure in Observance of Independence Day

The Medical Board’s office will be closed on Tuesday, July 4, 2017 in observance of Independence Day. The office will reopen on Wednesday at 8 a.m.

Upcoming Holiday Closure in Honor of Memorial Day

The Medical Board’s office will be closed on Monday, May 29, 2017 in honor of Memorial Day. The office will reopen on Tuesday at 8 a.m.

CT Exam Date Set for July 7

The date of the next Cosmetic Therapy exam will be Friday, July 7, 2017. The application must be submitted before 5pm Monday, June 26, 2017. Click here to submit an application.

Website Downtime

Part of the State Medical Board of Ohio’s online system will be down for maintenance on Thursday, April 6th. From 6-9p.m. users will not be able to access any information on the following licenses during that time:

Cosmetic therapist, massage therapists, physician assistants, acupuncturist, oriental medicine, anesthesiologist assistants, radiologist assistants, genetic counselor, limited branch schools.

The State Medical Board of Ohio recognizes and celebrates physicians on National Doctors' Day 2017.

The State Medical Board of Ohio recognizes and celebrates physicians on National Doctors' Day 2017.

In 1990, legislation was introduced in the House and Senate to establish a national Doctors' Day. Following overwhelming approval by the United States Senate and the House of Representatives, on October 30, 1990, President George H. W. Bush designated March 30th as "National Doctors' Day.

March 30th was selected because it is the anniversary of the first use of general anesthesia in surgery.

Update for Prescribers

The Ohio Board of Pharmacy has recently published a number of guidance documents regarding recent law and rule changes that may impact your prescribing practices.

  • TDDD Requirements for Controlled Substances: All locations that possess controlled substances are required to obtain licensure as a category III terminal distributor of dangerous drugs. Please be advised that this requirement takes effect on April 6, 2017. More information on this provision can be found by visiting: www.pharmacy.ohio.gov/TDDDcs.

  • Office-Based Opioid Treatment: Effective August 4, 2017, all locations that treat more than 30 individuals for opioid dependence or addiction using a controlled substance are required to obtain a license as a terminal distributor of dangerous drugs with an office-based opioid treatment classification. Please be advised that there are some exemptions to this requirement. More information on this provision can be found by visiting: www.pharmacy.ohio.gov/OBOT.

  • Effective April 1, 2017, all prescribers that possess compounded drugs or engage in the compounding of dangerous drugs (i.e. prescription drugs) must obtain a license as a terminal distributor of dangerous drugs (ORC 4729.541). More information on this provision can be found at: www.pharmacy.ohio.gov/prescribercompound.